Comparison between Ki-67 biomarker expression in primary breast cancer before and after neoadjuvant therapy.

被引：0
|
作者：
Zidan, Jamal [1 ]
机构：
[1] Ziv Med Ctr, Inst Oncol, Safed, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e24311
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e24311
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The role of Ki-67 expression gastric cancer as a prognostic biomarker
    Lee, Won Sup
    CANCER SCIENCE, 2018, 109 : 914 - 914
  • [22] Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
    von Minckwitz, Gunter
    Schmitt, Wolfgang D.
    Loibl, Sibylle
    Mueller, Berit M.
    Blohmer, Jens U.
    Sinn, Bruno V.
    Eidtmann, Holger
    Eiermann, Wolfgang
    Gerber, Bernd
    Tesch, Hans
    Hilfrich, Joern
    Huober, Jens
    Fehm, Tanja
    Barinoff, Jana
    Ruediger, Thomas
    Erbstoesser, Erhard
    Fasching, Peter A.
    Karn, Thomas
    Mueller, Volkmar
    Jackisch, Christian
    Denkert, Carsten
    CLINICAL CANCER RESEARCH, 2013, 19 (16) : 4521 - 4531
  • [23] Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis
    Nishimura, Reiki
    Osako, Tomofumi
    Okumura, Yasuhiro
    Hayashi, Mitsuhiro
    Arima, Nobuyuki
    BREAST CANCER, 2010, 17 (04) : 269 - 275
  • [24] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
    Robin L. Jones
    Janine Salter
    Roger A’Hern
    Ash Nerurkar
    Marina Parton
    Jorge S. Reis-Filho
    Ian E. Smith
    Mitchell Dowsett
    Breast Cancer Research and Treatment, 2009, 116 : 53 - 68
  • [25] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
    Jones, Robin L.
    Salter, Janine
    A'Hern, Roger
    Nerurkar, Ash
    Parton, Marina
    Reis-Filho, Jorge S.
    Smith, Ian E.
    Dowsett, Mitchell
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (01) : 53 - 68
  • [26] Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis
    Reiki Nishimura
    Tomofumi Osako
    Yasuhiro Okumura
    Mitsuhiro Hayashi
    Nobuyuki Arima
    Breast Cancer, 2010, 17 : 269 - 275
  • [27] Ki-67 as predictor of chemotherapy response in neoadjuvant chemotherapy for breast cancer
    Mishra, A. K.
    Kapoor, A.
    Tewari, S.
    Gond, S.
    Kumar, R.
    BREAST, 2015, 24 : S90 - S90
  • [28] Ki-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
    Kim, Kwan Il
    Lee, Kyung Hee
    Kim, Tae Ryung
    Chun, Yong Soon
    Lee, Tae Hoon
    Park, Heung Kyu
    JOURNAL OF BREAST CANCER, 2014, 17 (01) : 40 - 46
  • [29] Value of Ki-67 in prediction of response to neoadjuvant chemotherapy in breast cancer
    Kim, Kwanil
    Lee, Kyunghee
    Park, Heungkyu
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] The association between telomerase, histopathological parameters, and KI-67 expression in breast cancer
    Mokbel, K
    Parris, CN
    Ghilchik, M
    Williams, G
    Newbold, RF
    AMERICAN JOURNAL OF SURGERY, 1999, 178 (01): : 69 - 72
12345